DK568487D0 - Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse. - Google Patents

Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse.

Info

Publication number
DK568487D0
DK568487D0 DK568487A DK568487A DK568487D0 DK 568487 D0 DK568487 D0 DK 568487D0 DK 568487 A DK568487 A DK 568487A DK 568487 A DK568487 A DK 568487A DK 568487 D0 DK568487 D0 DK 568487D0
Authority
DK
Denmark
Prior art keywords
norcyclostat
norstatin
pharmaceutical preparations
polypeptides
preparations containing
Prior art date
Application number
DK568487A
Other languages
English (en)
Other versions
DK568487A (da
Inventor
Dennis Jay Hoover
Robert Louis Rosati
Ronald Thure Wester
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK568487D0 publication Critical patent/DK568487D0/da
Publication of DK568487A publication Critical patent/DK568487A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK568487A 1986-10-31 1987-10-30 Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse. DK568487A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92544986A 1986-10-31 1986-10-31
US6898287A 1987-07-01 1987-07-01

Publications (2)

Publication Number Publication Date
DK568487D0 true DK568487D0 (da) 1987-10-30
DK568487A DK568487A (da) 1988-05-01

Family

ID=26749566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK568487A DK568487A (da) 1986-10-31 1987-10-30 Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse.

Country Status (22)

Country Link
EP (1) EP0266950B1 (da)
JP (1) JPH07108901B2 (da)
KR (1) KR910002544B1 (da)
CN (1) CN1027271C (da)
AR (1) AR245732A1 (da)
AU (1) AU585180B2 (da)
CA (1) CA1310793C (da)
DE (1) DE3788626T2 (da)
DK (1) DK568487A (da)
EG (1) EG18378A (da)
ES (1) ES2061512T3 (da)
FI (1) FI90346C (da)
HU (1) HU207869B (da)
IE (1) IE61087B1 (da)
IL (1) IL84270A0 (da)
MY (1) MY103189A (da)
NO (1) NO173017C (da)
NZ (1) NZ222373A (da)
PH (1) PH25231A (da)
PL (1) PL151679B1 (da)
PT (1) PT86024B (da)
YU (1) YU46819B (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214129A (en) * 1985-01-23 1993-05-25 Abbott Laboratories Peptidylaminodiols
IL81234A (en) * 1986-01-16 1992-09-06 Abbott Lab Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
HU204285B (en) * 1986-10-31 1991-12-30 Pfizer Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them
US4977141A (en) * 1987-10-01 1990-12-11 G. D. Searle & Co. Peptidyl α-aminoacyl aminodiol carbamates as anti-hypertensive agents
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5217958A (en) * 1988-03-03 1993-06-08 E. R. Squibb & Sons, Inc. 1,2-hydroxy phosphonates and derivatives thereof
WO1989007940A1 (en) * 1988-03-03 1989-09-08 E.R. Squibb & Sons, Inc. 1,2-hydroxy phosphonates and derivatives thereof
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
US5736520A (en) * 1988-10-07 1998-04-07 Merrell Pharmaceuticals Inc. Peptidase inhibitors
EP0376040A3 (en) * 1988-12-27 1990-09-12 American Cyanamid Company N-phosphinyl di-and tripeptides as renin inhibitors
US4965372A (en) * 1989-01-19 1990-10-23 Pfizer Inc. Process and intermediates for isopropyl 3S-amino-2R-hydroxy-alkanoates
US5468732A (en) * 1989-02-16 1995-11-21 Pfizer Inc. Phosphorus containing renin inhibitors
WO1990009172A1 (en) * 1989-02-16 1990-08-23 Pfizer Inc. Phosphorus containing renin inhibitors
US5175181A (en) * 1989-12-04 1992-12-29 G. D. Searle & Co. Imidazolyl/imidazolylalkyl-N-terminal amino hydroxy
US5223512A (en) * 1989-12-04 1993-06-29 G. D. Searle & Co. Quinolonyl/quinolonylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
US5223534A (en) * 1989-12-04 1993-06-29 G. D. Searle & Co. Benzofuuranyl/benofuranylaklyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
US5217988A (en) * 1989-12-04 1993-06-08 G. D. Searle & Co. Indolyl indolylakyl-N-terminal cycloalkoxy-C-terminal amino hydroxyβ-amino acid derivatives
US5216013A (en) * 1989-12-04 1993-06-01 G. D. Searle & Co. Aralkyl-N-terminal cycloalkoxy-C terminal amino hydroxy β-amino acid derivatives
US5223532A (en) * 1989-12-04 1993-06-29 G. D. Searle & Co. Chromonyl/chromonylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino derivatives
US5180725A (en) * 1989-12-04 1993-01-19 G. D. Searle & Co. Quinoxalinyl/quinoxaliy; alkyl-N-terminal amino hydroxy
US5217991A (en) * 1989-12-04 1993-06-08 G. D. Searle & Co. Cycloalkyl/cycloalkylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
US5231111A (en) * 1989-12-04 1993-07-27 G. D. Searle & Co. Imidazolyl/imidazolylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
US5179102A (en) * 1989-12-04 1993-01-12 G. D. Searle & Co. Naphthyridinyl/naphthyridinylalkyl-n-terminal anino hydroxy β-amino acid derivatives
US5147888A (en) * 1989-12-04 1992-09-15 G. D. Searle & Co. N-terminal indolyy indolylalkylaminodiol β-amino acid derivatives
US5171751A (en) * 1989-12-04 1992-12-15 G. D. Searle & Co. Benzofuran/benzofuranalkyl-N-terminal amino hydroxy
US5212175A (en) * 1989-12-04 1993-05-18 G. D. Searle & Co. Benzothiophenyl benzothiophenylalkyl-N-terminal amino hydroxy β-amino acid derivatives
US5217989A (en) * 1989-12-04 1993-06-08 G. D. Searle & Co. Benothiophenyl/benzothiophenylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
ES2067635T3 (es) * 1989-12-04 1995-04-01 Searle & Co Derivados heterociclicos de beta-aminoacidos acilaminodiolicos.
US5175170A (en) * 1989-12-04 1992-12-29 G. D. Searle & Co. β-amino acid derivatives
US5223514A (en) * 1989-12-04 1993-06-29 G. D. Searle & Co. Quinolinyl/quinolinylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
US5210095A (en) * 1989-12-04 1993-05-11 G. D. Searle & Co. Chromonyl/chromonylalkyl-N-terminal amino hydroxy
US5180744A (en) * 1989-12-04 1993-01-19 G. D. Searle & Co. Aralkyl-N-terminal amino hydroxy
US5215996A (en) * 1989-12-04 1993-06-01 G. D. Searle & Co. Naphthyridinyl/naphthyridinylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
TW209870B (da) * 1990-01-18 1993-07-21 Pfizer
US5095119A (en) * 1990-03-08 1992-03-10 American Home Products Corporation Renin inhibitors
US5075451A (en) * 1990-03-08 1991-12-24 American Home Products Corporation Pyrrolimidazolones useful as renin inhibitors
US5064965A (en) * 1990-03-08 1991-11-12 American Home Products Corporation Renin inhibitors
US5023338A (en) * 1990-03-08 1991-06-11 American Home Products Corporation Renin inhibitors
US5278161A (en) * 1990-06-28 1994-01-11 Hoffmann-La Roche Inc. Amino acid derivatives useful as renin inhibitors
JPH04243835A (ja) * 1990-08-29 1992-08-31 Pfizer Inc 高眼圧症又は緑内障治療用薬剤組成物及び治療方法
US5442105A (en) * 1991-06-21 1995-08-15 Takasago International Corporation Process for producing cyclohexylbutyric acid derivative
JP2847584B2 (ja) * 1991-06-21 1999-01-20 高砂香料工業株式会社 シクロヘキシル酪酸誘導体及びその製造法
WO1993011799A1 (en) * 1991-12-18 1993-06-24 Pfizer Inc. Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation
US6153592A (en) * 1992-11-09 2000-11-28 Port Systems, Llc Enhancing the bioavailability of proteolytically labile therapeutic agents
US5872101A (en) * 1995-01-06 1999-02-16 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
EP0832065B1 (en) * 1995-06-06 2001-10-10 Pfizer Inc. Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
EP1134214A4 (en) * 1998-11-04 2004-12-15 Meiji Seika Kaisha PICOLINAMIDE DERIVATIVES AND PESTICIDES CONTAINING THESE DERIVATIVES AS ACTIVE INGREDIENT
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
US20020002152A1 (en) 2000-04-14 2002-01-03 Craig Richard A. Hydrazide and alkoxyamide angiogenesis inhibitors
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK110285A (da) * 1984-03-12 1985-09-13 Pfizer Polypeptider og polypeptidderivater indeholdende statin eller derivater deraf og farmaceutiske praeparater
DE3418491A1 (de) * 1984-05-18 1985-11-21 Merck Patent Gmbh, 6100 Darmstadt Diaminosaeurederivate
EP0190891A3 (en) * 1985-01-31 1988-04-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
US4743585A (en) * 1986-11-21 1988-05-10 Warner-Lambert Company Renin inhibitors
NZ222755A (en) * 1986-12-23 1989-11-28 Warner Lambert Co Renin inhibiting acyl peptide derivatives containing two to four amino acid residues, and pharmaceutical compositions

Also Published As

Publication number Publication date
MY103189A (en) 1993-05-29
IE61087B1 (en) 1994-09-21
PT86024A (en) 1987-11-01
AU8054187A (en) 1988-05-05
AR245732A1 (es) 1994-02-28
FI874787A (fi) 1988-05-01
AU585180B2 (en) 1989-06-08
NO874530L (no) 1988-05-02
NO173017B (no) 1993-07-05
DE3788626T2 (de) 1994-04-28
EP0266950A3 (en) 1990-04-11
FI874787A0 (fi) 1987-10-30
JPH07108901B2 (ja) 1995-11-22
HUT45270A (en) 1988-06-28
HU207869B (en) 1993-06-28
JPH07173134A (ja) 1995-07-11
KR880005152A (ko) 1988-06-28
DE3788626D1 (de) 1994-02-10
EP0266950B1 (en) 1993-12-29
FI90346B (fi) 1993-10-15
PL268521A1 (en) 1988-09-01
NO173017C (no) 1993-10-13
CA1310793C (en) 1992-11-24
KR910002544B1 (ko) 1991-04-23
YU46819B (sh) 1994-06-10
CN87101499A (zh) 1988-05-11
EG18378A (en) 1993-04-30
EP0266950A2 (en) 1988-05-11
FI90346C (fi) 1994-01-25
NO874530D0 (no) 1987-10-30
CN1027271C (zh) 1995-01-04
IL84270A0 (en) 1988-03-31
NZ222373A (en) 1989-09-27
ES2061512T3 (es) 1994-12-16
PT86024B (pt) 1990-07-31
PL151679B1 (en) 1990-09-28
IE872929L (en) 1988-04-30
PH25231A (en) 1991-03-27
YU198087A (en) 1989-02-28
DK568487A (da) 1988-05-01

Similar Documents

Publication Publication Date Title
DK568487D0 (da) Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse.
DK108388D0 (da) Piperazinylalkylheterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK214090D0 (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK162445C (da) Pyranopyridiner, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende pyranopyridinerne
DK288184D0 (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK162986C (da) 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater indeholdende disse
DK553988D0 (da) 4-aminopyridin-derivater og farmaceutiske praeparater indeholdende disse
DK108789A (da) Thiazolidin-2,4-dion-derivater og farmaceutiske praeparater indeholdende disse
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK78888A (da) Arylpiperazinylalkylenphenyl-heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK116989D0 (da) Polypeptider samt farmaceutiske praeparater indeholdende disse forbindelser
DK650089A (da) Furanalkylketoner og farmaceutiske praeparater deraf
DK92789A (da) Polypeptidderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK160944C (da) Modificerede beta2-mikroglobuliner og farmaceutiske praeparater indeholdende disse
DK21785A (da) Dihydropyridinforbindelser og farmaceutiske praeparater indeholdende disse
DK4487A (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK81185D0 (da) Carboxicam-enolester-forbindelser og farmaceutiske praeparater indeholdende disse
DK130890D0 (da) Peptider og farmaceutiske midler indeholdende disse
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
NO872223D0 (no) Bakteriociner og preparater inneholdende disse for anti-virus behandling.
DK488688A (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse
DK40292D0 (da) Dibenzofurancarboxamider og farmaceutiske praeparater indeholdende disse
DK547288D0 (da) 5-substituerede-3-phenyl-3-(1h-imidazol-1-ylmethyl)-2-methylisoxazolidiner og farmaceutiske praeparater indeholdende disse
DK162089C (da) 1-phenoxy-3-hydroxyindolylalkylamino-2-propanoler og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment